Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps

Global protein expression profiling can potentially uncover perturbations associated with common forms of heart disease. We have used shotgun MS/MS to monitor the state of biological systems in cardiac tissue correlating with disease onset, cardiac insufficiency and progression to heart failure in a time‐course mouse model of dilated cardiomyopathy. However, interpreting the functional significance of the hundreds of differentially expressed proteins has been challenging. Here, we utilize improved enrichment statistical methods and an extensive collection of functionally related gene sets, gaining a more comprehensive understanding of the progressive alterations associated with functional decline in dilated cardiomyopathy. We visualize the enrichment results as an Enrichment Map, where significant gene sets are grouped based on annotation similarity. This approach vastly simplifies the interpretation of the large number of enriched gene sets found. For pathways of specific interest, such as Apoptosis and the MAPK (mitogen‐activated protein kinase) cascade, we performed a more detailed analysis of the underlying signaling network, including experimental validation of expression patterns.

[1]  Jay X. Tang,et al.  Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. , 1997, Science.

[2]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[3]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[4]  L. Hawthorn,et al.  Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays , 2000, Circulation.

[5]  D. Kass,et al.  The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Mark D. Robinson,et al.  FunSpec: a web-based cluster interpreter for yeast , 2002, BMC Bioinformatics.

[7]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[8]  Timothy E Hewett,et al.  Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. , 2003, The Journal of clinical investigation.

[9]  Partha S. Vasisht Computational Analysis of Microarray Data , 2003 .

[10]  Ulrike Mende,et al.  Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.

[11]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[12]  C. Kuan,et al.  c‐Jun N‐terminal kinases (JNK) antagonize cardiac growth through cross‐talk with calcineurin–NFAT signaling , 2003, The EMBO journal.

[13]  G. Dorn,et al.  Manipulating Cardiac Contractility in Heart Failure: Data From Mice and Men , 2004, Circulation.

[14]  J. Yates,et al.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics. , 2004, Analytical chemistry.

[15]  Joaquín Dopazo,et al.  FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes , 2004, Bioinform..

[16]  Christine E Seidman,et al.  The genetic basis for cardiac remodeling. , 2005, Annual review of genomics and human genetics.

[17]  Purvesh Khatri,et al.  Ontological analysis of gene expression data: current tools, limitations, and open problems , 2005, Bioinform..

[18]  John N. Weinstein,et al.  High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID) , 2005, BMC Bioinformatics.

[19]  Martin Kuiper,et al.  BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..

[20]  K. Mani,et al.  Death begets failure in the heart. , 2005, The Journal of clinical investigation.

[21]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Andrew Emili,et al.  Multidimensional protein identification technology (MudPIT): Technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue , 2005, Journal of the American Society for Mass Spectrometry.

[23]  Paul Pavlidis,et al.  ErmineJ: Tool for functional analysis of gene expression data sets , 2005, BMC Bioinformatics.

[24]  J. Huss,et al.  Mitochondrial energy metabolism in heart failure: a question of balance. , 2005, The Journal of clinical investigation.

[25]  Michelle S. Scott,et al.  Global Survey of Organ and Organelle Protein Expression in Mouse: Combined Proteomic and Transcriptomic Profiling , 2006, Cell.

[26]  Emilio Hirsch,et al.  Integrin signalling: the tug-of-war in heart hypertrophy. , 2006, Cardiovascular research.

[27]  Peipei Ping,et al.  Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. , 2006, Journal of the American College of Cardiology.

[28]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[29]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.

[30]  Stefan Neubauer,et al.  The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.

[31]  C. Patterson,et al.  The Bitter End: The Ubiquitin-Proteasome System and Cardiac Dysfunction , 2007, Circulation.

[32]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[33]  Masahiro Fukuoka,et al.  Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. , 2007, The Canadian journal of cardiology.

[34]  E. Marcotte,et al.  Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation , 2007, Nature Biotechnology.

[35]  Chunxiang Zhang,et al.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? , 2007, The American journal of pathology.

[36]  T. Veenstra Global and targeted quantitative proteomics for biomarker discovery. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[37]  A. Emili,et al.  Analyzing the cardiac muscle proteome by liquid chromatography-mass spectrometry-based expression proteomics. , 2007, Methods in molecular biology.

[38]  Octave Noubibou Doudieu,et al.  CORUM: the comprehensive resource of mammalian protein complexes , 2007, Nucleic Acids Res..

[39]  David A. Kass,et al.  Tackling heart failure in the twenty-first century , 2008, Nature.

[40]  R. McKelvie,et al.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. , 2008, The Canadian journal of cardiology.

[41]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[42]  Andrew Emili,et al.  Interpretation of large-scale quantitative shotgun proteomic profiles for biomarker discovery. , 2008, Current opinion in molecular therapeutics.

[43]  Andrew Emili,et al.  Comparative Proteomics Profiling of a Phospholamban Mutant Mouse Model of Dilated Cardiomyopathy Reveals Progressive Intracellular Stress Responses*S , 2008, Molecular & Cellular Proteomics.

[44]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[45]  Daniel A Beard,et al.  Experimentally observed phenomena on cardiac energetics in heart failure emerge from simulations of cardiac metabolism , 2009, Proceedings of the National Academy of Sciences.

[46]  M. Klapholz Beta-blocker use for the stages of heart failure. , 2009, Mayo Clinic proceedings.

[47]  R. Fässler,et al.  The Tail of Integrins, Talin, and Kindlins , 2009, Science.

[48]  Junjun Zhang,et al.  BioMart Central Portal—unified access to biological data , 2009, Nucleic Acids Res..

[49]  Joaquín Dopazo,et al.  Formulating and testing hypotheses in functional genomics , 2009, Artif. Intell. Medicine.

[50]  Kenneth H. Buetow,et al.  PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..

[51]  Thomas Kislinger,et al.  Large-scale characterization and analysis of the murine cardiac proteome. , 2009, Journal of proteome research.

[52]  M. Fukuoka,et al.  Gelsolin Regulates Cardiac Remodeling After Myocardial Infarction Through DNase I–Mediated Apoptosis , 2009, Circulation research.

[53]  G. Dorn Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. , 2008, Cardiovascular research.

[54]  Lincoln Stein,et al.  Reactome knowledgebase of human biological pathways and processes , 2008, Nucleic Acids Res..

[55]  Hans-Werner Mewes,et al.  CORUM: the comprehensive resource of mammalian protein complexes , 2007, Nucleic Acids Res..

[56]  B. Garcia,et al.  Proteomics , 2011, Journal of biomedicine & biotechnology.